Biotechnology / Medical Research

Global Health Ventures Inc. To Close $500,000 Private Placement

Global Health Ventures Inc. announced that it has completed a non-brokered private placement using Regulations S (Reg S) Exemption from the registration statement. The Company issued 625,000 units at a price of $0.80 per unit for gross proceeds of $500,000. Each unit consists of one common share and...

Biotron Limited Announces Exercise Of Options

Biotron Limited announced that it has issued 6,418,049 fully paid ordinary shares at AUD0.10 upon exercise of options.

Lorus Therapeutics Inc. Files Registration Statement With SEC

Lorus Therapeutics Inc. announced that it has filed a Registration Statement on Form F-1 (Registration Statement) with the United States Securities and Exchange Commission (SEC) for an offering of up to $17,500,000 of units in the United States. Global Hunter Securities, LLC has been engaged to act...

Lorus Therapeutics Inc. Files Registration Statement With SEC

Lorus Therapeutics Inc. announced that it has filed a Registration Statement on Form F-1 (Registration Statement) with the United States Securities and Exchange Commission (SEC) for an offering of up to $17,500,000 of units in the United States. Global Hunter Securities, LLC has been engaged to act...

Restructuring & Reorganization

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider: Roth Capital Partners, Inc.
$10.0
Provider: Jefferies & Company, Inc.
$75.0
Provider: Auerbach Grayson & Co., Inc.
$10.0
Provider: Auerbach Grayson & Co., Inc.
$25.0
Provider: Auerbach Grayson & Co., Inc.
$25.0

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.